Back to news
Saplegal advised HDBI as an institutional investor, in Kos BioVentures (A.K.E.S.)
30-07-2026
We are pleased to have advised Hellenic Development Bank of Investments, on its participation as an institutional investor in Kos BioVentures (A.K.E.S), the first Greece-based venture capital fund dedicated to life sciences.Kos BioVentures focuses on investments in biotechnology, therapeutics, pharmaceutical services and health technologies, while aiming to strengthen links between the Greek and European innovation ecosystems and the US biopharma market.